Add Yahoo as a preferred source to see more of our stories on Google. Are Americans paying nearly $500 for an inhaler that would cost just $7 overseas? U.S. Sen. Tammy Baldwin, D-Wis., says there is a ...
On Jan. 21, 2024, a 22-year-old Wisconsin man died from a severe asthma attack days after he was unable to purchase his regular inhaler due to a sudden price hike and opted to pay his rent instead.
Please provide your email address to receive an email when new articles are posted on . The Allergy & Asthma Network (AAN) applauds corporate decisions to cap inhaler prices at $35. Two caps are set ...
The price of asthma medication has soared in the U.S. over the past decade and a half. I’m a health law professor at Villanova University, where I study whether patients can get the medicines they ...
U.S. inhaler prices have sparked recent scrutiny from the Senate Health, Education, Labor and Pensions (HELP) committee. In response, several companies are capping out-of-pocket prices.
Medical inhalers sit on a table as a prop as US President Joe Biden speaks about lowering healthcare costs in the Indian Treaty Room of the White House in Washington, DC, on April 3, 2024. JIM ...
LA CROSSE, Wis. (WEAU) - Back in January, Senator Tammy Baldwin launched an investigation into inhaler prices. Baldwin says the investigation found the four major pharmaceutical companies that sell ...
When 22-year-old Cole Schmidtknecht tried to get a refill on the inhaler prescribed by his doctor to prevent asthma attacks, the medication that had formerly cost him less than $70 at his Appleton, ...
AstraZeneca is capping out-of-pocket costs for inhalers and related medication at no more than $35 per month, the drugmaker announced Monday. The Britain based pharma giant said the expanded savings ...
Are Americans paying nearly $500 for an inhaler that would cost just $7 overseas? U.S. Sen. Tammy Baldwin, D-Wis., says there is a vast difference in the cost of prescriptions in the United States and ...
Experts say a key reason why inhaler prices remain so high in the U.S. is that there is very little generic competition. The Senate committee, in a letter to the pharma CEOs, cited an online global ...